MedTrace Logo

Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

NCT05153629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-10-22

Study results available
· View outcomes & findings →

Summary

The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.

Conditions

  • Kidney Stone
  • Ureteral Calculi
  • Nephrolithiasis

Interventions

DEVICE

TENS

TENS device used four times a day for 60 minutes each time

Sponsors & Collaborators

Principal Investigators

  • Simon Conti, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2023-10-01
Completion
2023-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05153629 on ClinicalTrials.gov